We’ve had the great opportunity to talk to the Vice President and General Manager, Cihan Serdar Kizilcik, and Jacqueline Anne Del Castillo, the Public Affairs and Communications Manager, of Novo Nordisk Philippines, producer of nearly half of insulin and other life-saving medicines in the world. We talk about their commitment to the Sustainable Development Goals. We focus on SDG 3 on good health and well-being, as they want to not only cure the symptoms of diabetes, but also prevent obesity, diabetes and other serious chronic diseases from happening in the first place. We also dive in to SDG 12 on responsible consumption and production, as they are optimizing the recyclability of their insulin pens through their programme Circular for Zero. We also talk about their ambitious goal of wanting to achieve 100% renewable electricity throughout the supply chain, as suppliers make up 80% of Novo Nordisk’s carbon footprint. Lastly, we dive into how Novo Nordisk is engaged in gender equality, diversity and inclusion, with 51% female employees and many of them in leadership positions.
Listen in on this podcast to hear about the visionary sustainability initiatives. Here’s a snippet of what we talked about:
“So focusing only on the problem, is not going to help us. In the Philippines the number of people with type 2 diabetes today is only 4 million, but it is increasing very rapidly and that is a problem, because in a country where everything about healthcare is out of pocket still, that creates a big problem for economic prosperity and development as well. So we are trying to reach authorities to initiate the projects so that we can actually be a partner in creating broader awareness.”